Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
123.51
-0.01 (-0.01%)
At close: Jun 29, 2026, 4:00 PM EDT
123.51
0.00 (0.00%)
After-hours: Jun 29, 2026, 4:10 PM EDT
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $9.76 billion as of June 29, 2026. Its market cap has increased by 74.40% in one year.
Market Cap
9.76B
Enterprise Value
8.47B
1-Year Change
74.40%
Ranking
Category
Stock Price
$123.51
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $9.76B, an increase of 1,125.81%. That is a compound annual growth rate of 66.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 9.76B | 24.91% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 11.16B |
| Arrowhead Pharmaceuticals | 11.11B |
| Bio-Techne | 11.06B |
| Krystal Biotech | 10.97B |
| Summit Therapeutics | 10.87B |
| Apogee Therapeutics | 9.93B |
| Corcept Therapeutics | 9.37B |
| Praxis Precision Medicines | 9.14B |